Optimized Biomimetic Syntheses of Discorhabdin B and Aleutianamine Drives a Deeper Exploration of Their Anticancer Potential
Journal of the American Chemical Society · 2026
DOI: 10.1021/jacs.6c06599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2026. Verfasst von Nicholas L Magann und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, 1102 Natural Sciences II, University of California, Irvine, California 92697, United States. Hauptthemen laut MEDLINE: Antineoplastic Agents, Biomimetic Materials, Pyrroloiminoquinones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, 1102 Natural Sciences II, University of California, Irvine, California 92697, United States.
- Clinical Genomics and Therapeutics Division, Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, Arizona 85004, United States.
- HonorHealth Research Institute, Scottsdale, Arizona 85258, United States.
- Department of Pharmaceutical Sciences, University of California, 856 Health Sciences Road, Suite 5400, Irvine, California 92697, United States.
ORCID-Profile: Christopher D Vanderwal
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- Deutsche Forschungsgemeinschaft
- National Institutes of Health (NIH)
- Kemper & Ethel Marley Foundation
- John E. Sabga Foundation via Maple Leaf International School
- National Science Foundation (NSF)
- Purple Pansies Foundation
Zitieren
APA
Magann, N. L., Barnes, G. L., Schioldager, R., Hörmann, F. M., Muñoz, R., Han, H., Von Hoff, D., & Vanderwal, C. D. (2026). Optimized Biomimetic Syntheses of Discorhabdin B and Aleutianamine Drives a Deeper Exploration of Their Anticancer Potential. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.6c06599
Vancouver
Magann NL, Barnes GL, Schioldager R, Hörmann FM, Muñoz R, Han H, et al. Optimized Biomimetic Syntheses of Discorhabdin B and Aleutianamine Drives a Deeper Exploration of Their Anticancer Potential. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.6c06599
BibTeX
@article{Magann2026,
author = {Magann, Nicholas L and Barnes, Griffin L and Schioldager, Ryan and Hörmann, Fabian M and Muñoz, Rubén and Han, Haiyong and Von Hoff, Daniel and Vanderwal, Christopher D},
title = {Optimized Biomimetic Syntheses of Discorhabdin B and Aleutianamine Drives a Deeper Exploration of Their Anticancer Potential},
journal = {Journal of the American Chemical Society},
year = {2026},
doi = {10.1021/jacs.6c06599}
}
EUVIMED